Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 108,636	$ 154,083
Short-term investments	346,597	418,801
Accounts receivable, net	19,454	7,602
Inventory	17,696	366
Short-term deposits	13,473	10,029
Other receivable	3,629	3,635
Collaboration receivable, net	12,316	0
Prepaid expenses and other current assets	9,875	8,541
Total current assets	531,676	603,057
Long-term investments	62,627	119,520
Property and equipment, net	0	0
Right-of-use asset, net	1,629	2,022
Restricted cash	217	217
Total assets	596,149	724,816
Current liabilities:
Accounts payable	17,353	11,626
Collaboration payable, net	0	19,231
Royalty payable	4,783	307
Accrued expenses and other current liabilities	71,066	59,789
Current portion of royalty interest financing liability	19,435	12,116
Current portion of right-of-use liability	344	471
Current portion of capital lease	6	9
Total current liabilities	112,987	103,549
Long-term liabilities:
Royalty interest financing liability, less current portion	324,413	331,565
Right-of-use liability, less current portion	1,325	1,578
Total long-term liabilities	325,738	333,143
Total liabilities	438,725	436,692
Commitments and contingencies (Note 12)
Stockholders’ equity:
Preferred stock, $0.001 par value, 10,000,000 shares authorized; 0 shares outstanding at June 30, 2025 and December 31, 2024	0	0
Common stock, $0.0001 par value, 200,000,000 shares authorized; 86,059,077 and 85,694,443 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively	9	9
Additional paid-in capital	1,534,981	1,509,110
Accumulated other comprehensive (loss) gain	285	163
Accumulated deficit	(1,377,851)	(1,221,158)
Total stockholders’ equity	157,424	288,124
Total liabilities and stockholders’ equity	$ 596,149	$ 724,816